logo

For the Inventor, By the Inventor

Jerusalem, Israel

Immunovative Therapies, Ltd.

Calculating rank
USPTO Granted Patents = 33

% Expired Patents = 27.3



Trademarks = 1

Forward Citations = 218

Loading Chart...
Loading Chart...

1 inventor (with patents filed for the assignee):

goldMedal Michael Har-Noy (33 out of 46 patents)


Core Competencies:
T-Cell Therapy
Allogeneic Cell Therapy
Immunostimulatory Devices
Biologic Drug Distribution
Th1 Characteristics
Cytolytic Properties
IL-12 Induction
Ablative Immunotherapy
CD4 Cell Composition
Cytokine Response
Biodegradable Devices
Therapeutic Immune Effect

33 patents:

1. 10385315 - Cells expressing Th1 characteristics and cytolytic properties (2019-08-20),
2. 10350242 - Methods for handling biological drugs containing living cells (2019-07-16),
3. 10318712 - Automated device for biologic drug distribution (2019-06-11),
4. 10272143 - Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome (2019-04-30),
5. 9782463 - Method for allogeneic cell therapy (2017-10-10),
6. 9695397 - Th1 vaccination priming for active immunotherapy (2017-07-04),
7. 9593308 - Device for enhancing immunostimulatory capabilities of T-cells (2017-03-14),
8. 9511127 - Method to formulate T-cells (2016-12-06),
9. 9352001 - Method for stimulating a host immune system (2016-05-31),
10. 9320794 - Ablative immunotherapy (2016-04-26),
11. 9301977 - Method for allogeneic cell therapy (2016-04-05),
12. 9272001 - Ablative immunotherapy (2016-03-01),
13. 9233156 - Induction of IL-12 using immunotherapy (2016-01-12),
14. 8883974 - Device for enhancing immunostimulatory capabilities of T-cells (2014-11-11),
15. 8865224 - Allogeneic cellular immunotherapy for opportunistic infection (2014-10-21),
Company Overview
Immunovative Therapies, Ltd. is a biotechnology company based in Jerusalem, Israel, specializing in the development of innovative immunotherapy solutions. The organization focuses on harnessing the body's immune system to combat various diseases, particularly cancer. Through advanced research and technology, Immunovative Therapies aims to create effective treatments that enhance patient outcomes. Their work is characterized by a commitment to scientific excellence and a dedication to improving therapeutic options in the field of immunology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

33 Patents

#8 in Jerusalem

#165 in Israel

#20,172 in the World

Jerusalem, IL
Jerusalem, Israel

Immunovative Therapies, Ltd.

Forward Citations = 218

1 inventor:

goldMedal Michael Har-Noy (33 out of 46 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunovative Therapies, Ltd.. Retrieved from https://idiyas.com/company/immunovative-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…